Considering that with age adult DS individuals accumulate oxidative damage in brain associated with an increased risk to develop Alzheimer-like dementia, modulation of the BACH1/Nrf2 axis in DS may represent a promising therapeutic strategy. Here, BACH1 is linked to Dravet syndrome.